Severe sepsis is the leading cause of death in intensive care units and accounts for 9% of deaths in the United States annually (1) . Innate immune responses are critical for protection against lethal infection and tissue injury, but the uncontrolled production of proinfl ammatory cytokines, including TNF, IL-1, and high mobility group box 1 (HMGB1), causes the development of severe sepsis (2) (3) . Counterregulatory antiinfl ammatory mediators, such as glucocorticoids and IL-10, normally suppress proinfl ammatory cytokine production to prevent excessive infl ammatory responses (4, 5) . We recently discovered that the central nervous system also regulates proinfl ammatory cytokine production through the eff erent vagus nerve (5) (6) (7) (8) (9) . Termed the "cholinergic antiinfl ammatory pathway" because acetylcholine is the principal vagus neurotransmitter, activation of this mechanism via vagus nerve stimulation can control the production of proinfl ammatory cytokines in experimental models of systemic infl ammation, including lethal endotoxemia, hemorrhagic shock, and ischemia-reperfusion injury (6) (7) (8) (9) (10) .
Acetylcholine inhibits the production of proinfl ammatory cytokines from endotoxinstimulated macrophages through a mechanism dependent on the α7 nicotinic acetylcholine receptor subunit (α7nAChR) (8, 11, 12) . Electrical vagus nerve stimulation fails to reduce serum TNF levels in α7nAChR-defi cient mice, and macrophages derived from these knockout mice are insensitive to the cytokine-inhibiting eff ects of cholinergic agonists, indicating that the α7nAChR is required for the antiinfl ammatory eff ects of the vagus nerve (8) . α7 agonists
Splenectomy inactivates the cholinergic antiinfl ammatory pathway during lethal endotoxemia and polymicrobial sepsis
The innate immune system protects against infection and tissue injury through the specialized organs of the reticuloendothelial system, including the lungs, liver, and spleen. The central nervous system regulates innate immune responses via the vagus nerve, a mechanism termed the cholinergic antiinfl ammatory pathway. Vagus nerve stimulation inhibits proinfl ammatory cytokine production by signaling through the 7 nicotinic acetylcholine receptor subunit. Previously, the functional relationship between the cholinergic antiinfl ammatory pathway and the reticuloendothelial system was unknown. Here we show that vagus nerve stimulation fails to inhibit tumor necrosis factor (TNF) production in splenectomized animals during lethal endotoxemia. Selective lesioning of the common celiac nerve abolishes TNF suppression by vagus nerve stimulation, suggesting that the cholinergic pathway is functionally hard wired to the spleen via this branch of the vagus nerve. Administration of nicotine, an 7 agonist that mimics vagus nerve stimulation, increases proinfl ammatory cytokine production and lethality from polymicrobial sepsis in splenectomized mice, indicating that the spleen is critical to the protective response of the cholinergic pathway. These results reveal a specifi c, physiological connection between the nervous and innate immune systems that may be exploited through either electrical vagus nerve stimulation or administration of 7 agonists to inhibit proinfl ammatory cytokine production during infection and tissue injury.
can inhibit activation of the transcriptional factor NF-κB, prevent secretion of HMGB1 and TNF, and improve survival during experimental polymicrobial sepsis (11, 12) . Collectively, these and other studies indicate that the cholinergic antiinfl ammatory pathway has a critical role in modulating the immune response to infection and injury (13, 14) .
The reticuloendothelial system consists of macrophages and monocytes that target foreign pathogens in the lungs, liver, spleen, and other organs (15) . These immune cells were originally grouped together because they engulfed vital dyes from the blood. It has since become clear that these cells are essential to the immediate, early response to circulating microbes and LPS, the bacterial endotoxin that stimulates tissue macrophages to secrete lethal quantities of proinfl ammatory cytokines (16) . Bacteria and endotoxin localize to macrophages primarily in the spleen and liver, which in turn become activated to produce proinfl ammatory cytokines (17) . Because the cholinergic antiinfl ammatory pathway inhibits early proinfl ammatory cytokine production during endotoxemia, we reasoned that the principal physiological components of this pathway must reside there.
Accordingly, here we examined the eff ects of vagus nerve stimulation and administration of α7nAChR agonists on proinfl ammatory cytokine production in organs of the reticuloendothelial system during lethal endotoxemia and polymicrobial sepsis. The results indicate that splenectomy and selective abdominal vagotomy inactivate the antiinfl ammatory eff ects of either vagus nerve stimulation or administration of α7nAChR agonists, and reveal that the spleen is a specifi c and essential target of the cholinergic antiinfl ammatory pathway.
RESULTS AND DISCUSSION
Spleen response to antiinfl ammatory effects of vagus nerve stimulation To explore the relationship between the reticuloendothelial system and the cholinergic antiinfl ammatory pathway, we fi rst measured individual organ TNF concentrations during lethal endotoxemia (Fig. 1 A) . Endotoxin administration significantly increases TNF production in the spleen by a factor of 30 as compared with six-and twofold increases in the lung and liver, respectively. Vagus nerve stimulation signifi cantly reduces TNF levels in the spleen (94%) and liver (40%), but not in the lung (20%) (Fig. 1 A) . Endotoxin signifi cantly increases TNF mRNA levels in the spleen and liver by 70-and 23-fold, respectively. Vagus nerve stimulation signifi cantly decreases TNF mRNA levels in the spleen, but it does not reduce TNF mRNA levels in the liver (Fig. 1 B) . The reduction in splenic TNF mRNA levels mediated by vagus nerve stimulation was confi rmed using the RNase protection assay (not depicted). Collectively, these fi ndings reveal that the spleen is an important source of TNF production that is regulated by the antiinfl ammatory eff ects of vagus nerve stimulation.
Vagus nerve stimulation fails to inhibit systemic TNF production in splenectomized animals
To determine the role of the spleen in the cholinergic antiinfl ammatory pathway, we subjected rats to splenectomy or sham surgery before lethal endotoxemia (Fig. 2 A) . Splenectomy signifi cantly reduces serum TNF levels by 80% as compared with sham controls, which match the 77% reduction in serum TNF levels after vagus nerve stimulation (Fig. 2 A) . In contrast to the antiinfl ammatory eff ects of vagus nerve stimulation in intact animals, we observed that vagus nerve stimulation fails to inhibit serum TNF levels in splenectomized animals ( Fig. 2 A) . To explore the functional anatomy of this vagal antiinfl ammatory pathway to the spleen, we performed selective abdominal vagotomies before vagus nerve stimulation (Fig. 2 , B and C). Inferior to the rat diaphragm, the ventral vagus nerve trunk divides into gastric, hepatic, and celiac branches, and the dorsal vagus trunk divides into gastric and celiac branches (18, 19) . Cervical vagus nerve stimulation attenuates splenic and serum TNF levels in animals subjected to ventral subdiaphragmatic vagotomy. Common celiac branch vagotomy, however, abrogates the TNF-suppressing eff ects of cervical vagus nerve stimulation in both the spleen and serum, indicating that intact vagal innervation via the common celiac branches are required for vagus nerve regulation of splenic and systemic TNF.
Vagus nerve regulation of TNF production in the spleen requires the 7nAChR
Regulation of serum TNF levels by vagus nerve stimulation is dependent on the α7nAChR (8, 11, 12). To determine the importance of the local α7nAChR antiinfl ammatory response in the spleen, we measured TNF levels in the spleen after vagus nerve stimulation of α7nAChR knockout mice (Fig.  3 A) . Western blot and immunohistochemical analyses confi rmed the presence of splenic α7nAChR expression in wildtype mice, but not in α7nAChR knockout mice (Fig. 3 A,  inset) . Vagus nerve stimulation in α7nAChR knockout mice fails to inhibit TNF production in the spleen. Consistent with our previous studies, vagus nerve stimulation in α7nAChR knockout mice also fails to inhibit serum TNF levels (Fig. 3 B) .
The α7nAChR response in the spleen was studied using endotoxin-stimulated splenocytes isolated from wild-type and α7nAChR-defi cient animals. Endotoxin signifi cantly increases TNF levels in both wild-type and α7 knockout splenocytes. Acetylcholine signifi cantly inhibits TNF release in endotoxin-stimulated splenocytes from wild-type mice, but not in splenocytes from α7nAChR-defi cient animals ( Fig. 3 C) , indicating that like macrophages, splenocytes are unable to respond to cholinergic antiinfl ammatory signaling in the absence of the α7nAChR. To determine the cytokine specifi city of splenic cholinergic signaling, we analyzed the expression of TGF-β, an antiinfl ammatory cytokine (20) . Endotoxin stimulation increased TGF-β expression in splenocyte cultures from wild-type and α7nAChR-defi cient animals. Acetylcholine did not signifi cantly alter TGF-β expression in splenocyte cultures obtained from either wild-type or α7nAChR-defi cient animals (Fig. 3 D) , suggesting that the pathway is specifi c. These fi ndings indicate that the α7nAChR response is a necessary molecular component of vagus nerve antiinfl ammatory signaling in the spleen.
Nicotine worsens survival in splenectomized animals with lethal polymicrobial sepsis Administration of nicotine protects mice against the lethality of polymicrobial sepsis by inhibiting proinfl ammatory cytokine production via an α7nAChR-dependent mechanism (11). To determine the role of the spleen in this pathway, splenectomized mice subjected to cecal perforation were treated with nicotine. We observed that nicotine not only fails to protect against sepsis lethality in splenectomized mice, but it actually worsens survival (Fig. 4 A) . Previously, the survival benefi ts of nicotine were found to correlate with reduced serum levels of HMGB1, a necessary and suffi cient mediator of lethal systemic infl ammation (11). Here we observed that nicotine not only fails to inhibit, but it actually signifi cantly increases serum HMGB1 levels in splenectomized animals (Fig. 4 B) . There were no diff erences in circulating TNF, IL-12, IFN-γ, or IL-10 levels between vehicle-or nicotine-treated animals (not depicted). These fi ndings indicate that the protective eff ects of nicotine in lethal sepsis require the spleen, and suggest that splenectomy eliminates nicotine's ability to regulate circulating HMGB1 levels.
Cholinergic antiinfl ammatory pathway innervation of the spleen
The innate immune system coordinates the early and rapid defense against invasive pathogens and toxins (21) (22) . The aff erent, sensory arm of the vagus nerve is critical to the central nervous system's response to toxins in the peripheral immune environment (23) (24) . The cholinergic antiinfl ammatory pathway is the eff erent arm of this vagus nerve-mediated, brain-toimmune pathway that inhibits systemic proinfl ammatory cytokine production by signaling through the α7nAChR (5-12). We studied the functional relationship between the innate immune system and the cholinergic antiinfl ammatory pathway and found a specifi c, α7nAChR-dependent vagus nerve pathway to the spleen that inhibits proinfl ammatory cytokine production during lethal endotoxemia and polymicrobial sepsis. Interruption of this pathway via splenectomy or selective abdominal vagotomy completely abolishes the protective, antiinfl ammatory eff ects of the cholinergic antiinfl ammatory pathway.
Vagus nerve stimulation signifi cantly reduces TNF protein levels in the spleen and liver, and specifi cally reduces TNF mRNA levels in the spleen, but not liver. These fi ndings indicate that the vagus nerve is an early and local modulator of proinfl ammatory cytokine production in the spleen and suggest that this specifi c regulation of TNF production occurs at the transcriptional level. Splenectomy reduces systemic TNF production by 80% during lethal endotoxemia, suggesting that the spleen is a major contributor to systemic TNF production in this experimental model. Vagus nerve stimulation fails to inhibit proinfl ammatory cytokine production after splenectomy or selective interruption of the abdominal vagus nerve at the common celiac branch. Thus, signals originating in the vagus nerve traverse the common celiac branch to control proinfl ammatory cytokine production in the spleen.
Vagus nerve stimulation fails to regulate splenic TNF production in α7nAChR-defi cient mice, and splenocytes from α7 knockout mice do not respond to in vitro stimulation with acetylcholine. Administration of the α7 nicotinic nicotine to splenectomized animals signifi cantly increases mortality and serum HMGB1 levels, whereas we previously demonstrated that nicotine signifi cantly improves survival and attenuates circulating HMGB1 levels in nonsplenectomized mice by acting through the α7nAChR (11, 12) . These results indicate that the spleen is essential to the α7nAChR-dependent protective antiinfl ammatory response. It is possible that the worsened survival after nicotine treatment is related to nicotinic suppression of normal immune responses in the absence of the spleen. In agreement with this hypothesis, previous studies indicate that nicotine can signifi cantly impair antimicrobial activity in macrophages lacking the α7nAChR via its action on other non-α7 acetylcholine receptor subtypes (25) . Nicotine increases serum HMGB1 levels in splenectomized animals. BALB/c mice were subjected to splenectomy before cecal ligation and puncture, and nicotine (400 μg/kg, i.p.) or vehicle treatment began 24 h after surgery. Blood was collected 44 h after surgery, and serum HMGB1 concentration was determined by Western blot and densitometric analysis. Data are presented as mean ± SEM (n > 8 per group). **, P < 0.05.
BRIEF DEFINITIVE REPORT
Collectively, these fi ndings have important implications for the development of therapeutic, selective α7nAChR agonists. It may be necessary to develop methods that specifi cally target the critical, α7nAChR antiinfl ammatory response peripherally in the spleen as well as to consider methods to stratify patients who may or may not benefi t from activation of the cholinergic antiinfl ammatory pathway. Vagus nerve modulation of the spleen may represent the functionally, hard-wired counterpart to humoral antiinfl ammatory responses, such as the hypothalamic-pituitaryadrenal axis (26) . The neural connection between the vagus nerve and the spleen can allow for rapid and precise control of systemic cytokine production. It may also control the traffi cking of infl ammatory cells to distant sites (27) . Vagus nerve stimulation is clinically approved for the treatment of medically refractory seizures, and more than 25,000 individuals have undergone this safe and well-tolerated therapy worldwide (28, 29) . Future studies are needed to explore the protective eff ects of vagus nerve stimulation and α7nAChR agonists in the treatment of systemic infl ammation and sepsis.
MATERIALS AND METHODS

Animals.
Adult male Lewis rats (280-300 g; Charles River Laboratories), male 8-12-wk-old BALB/c mice (25-30 g; Taconic), and male and female 8-12-wk-old α7nAChR-defi cient mice (C57BL/6 background) as well as wild-type littermates (The Jackson Laboratory) were housed at 25°C on a 12-h light/dark cycle. Standard animal chow and water were freely available. All experiments were performed under protocols approved by the Institutional Animal Care and Use Committee of The Feinstein Institute for Medical Research, North Shore-LIJ Health System. Endotoxemia. Endotoxin (Escherichia coli LPS 0111:B4; Sigma-Aldrich) was dissolved in sterile pyrogen-free PBS and sonicated for 30 min immediately before use. Animals received an LD 50-75 dose of LPS (7.5-15 mg/kg). Blood was collected after 90-120 min, allowed to clot for 2 h at room temperature, and centrifuged for 15 min at 2,000 g. TNF concentrations were measured by ELISA (R&D Systems).
Vagus nerve stimulation. Animals were anesthetized i.m. with 100 mg/kg ketamine and 10 mg/kg xylazine, and subjected to sham surgery (sham) or left cervical vagotomy with electrical stimulation of the distal nerve trunk. In sham-operated animals, the vagal trunk was exposed but not divided. The nerve trunk was placed across a bipolar platinum electrode (Plastics One) connected to a stimulation module (STM100A) controlled by AcqKnowledge software (Biopac Systems). Stimulation (1 V, 2 ms, 5 Hz) was applied for 10 min before and after endotoxin administration.
Subdiaphragmatic vagotomy. Animals were anesthetized with ketamine and xylazine. After an upper midline laparotomy, the stomach was retracted inferiorly to access the common celiac and ventral vagus nerve trunks, and vagotomy was performed by ligating and excising at least 1 cm of either the ventral vagus nerve or both common celiac branches. For sham controls, the vagal trunks were exposed but not ligated.
Cecal ligation and puncture. Cecal ligation and puncture were performed on BALB/c mice as described previously (11) . Animals received antibiotic (0.5 mg/kg Primaxin, s.c.) and 0.9% normal saline (20 ml/kg body weight, s.c.) immediately after surgery. i.p. administration of 400 μg/kg nicotine or vehicle injection (1× PBS) began 24 h after surgery, and thereafter twice a day for 3 d. Animals were killed after 44 h for serum cytokine analysis. Serum HMGB1 levels were determined by Western blot as we described previously (11) . HMGB1 concentrations were calculated against standard curves of purifi ed recombinant HMGB1, which was purifi ed as described previously (11) . Serum TNF, IL-12, IFN-γ, and IL-10 levels were measured using Cytometric Bead Array (Becton Dickinson) according to the manufacturer's instructions.
Splenectomy. Mice were anesthetized with ketamine and xylazine. The spleen was identifi ed after a midline laparotomy incision and removed after appropriate blood vessel ligation. Sham animals underwent laparotomy without splenectomy.
Splenocyte culture. Spleens were mechanically disrupted with a 100-μm pore cell strainer (BD Falcon), erythrocytes were lysed in solution (Gentra Systems) for 10 min, and intact cells were washed twice in PBS. Cells were resuspended in medium (RPMI, FBS 10%, 2 mM l-glutamine, 100 U/ml penicillin/100μg/ml streptomycin) and plated at a fi nal density of 5 × 10 5 cells/well. Splenocytes were incubated for 10 h with 50 ng/ml LPS (E. coli 0111:B4; Sigma-Aldrich) plus or minus acetylcholine (0, 1, 10, and 100 μM; Sigma-Aldrich) combined with 1 mM pyridostigmine bromide (Sigma-Aldrich). Supernatant cytokine levels were measured by ELISA (R&D Systems).
Quantitative RT-PCR. Frozen spleen and liver samples were homogenized before total RNA isolation using an RNeasy kit and QIAshredder mini-spin columns (QIAGEN) and treated with DNase to remove genomic contamination (QIAGEN). The relative expression of TNF mRNA was determined by quantitative real-time PCR using TaqMan technology using the Eurogentec's RTqPCR mastermix and the ABI PRISM 7700 Sequence Detection System. Optimal concentrations of primers, probes, and the RNA were standardized.
TNF primer (forward: G C T G C C C C G A C T A T G T G-C T , reverse: G A C T T T C T C C T G G T A T G A A A T G G C )
was added at a fi nal concentration of 900 nM. Mouse GAPDH was used as an internal control gene, and mouse GAPDH primers (forward: T G T G T C C G T C G T G G A T C-T G A , reverse: C C T G C T T C A C C A C C T T C T T G A ) and the GAPDH TaqMan probe (C C G C C T G G A G -A A A C C T G C C A ) were added at fi nal concentrations of 500 nM and 100 nM, respectively. The thermal cycler conditions were 35 cycles of 94°C for 20 s, 55°C for 20 s, and 72°C for 30 s. Data were analyzed using Sequence Detection System software version 1.9.1. Relative expression of the TNF gene in the spleen and liver obtained from mice treated with endotoxin or endotoxin plus vagus nerve stimulation was calculated in comparison to vehicle-treated control samples using the delta delta Ct method (User Bulletin no. 2; Applied Biosystems). All samples were run in duplicate.
RNase protection assay. Total RNA was extracted using the RNeasy Mini kit (catalog no. 74104; QIAGEN) according to the manufacturer's instructions (Tel-Test B Inc.). Purity and integrity of the preparation were verifi ed by electrophoresis on 1.2% agarose/17% formaldehyde gels and by RT-PCR for TNF mRNA. Extraction effi ciency was measured by absorbance to normalized concentrations of total RNA. TNF and actin mRNA in the spleen and liver were measured by RNase protection assay using the RPA III kit (catalog no. 1415; Ambion). The antisense RNA probe was labeled with 800 Ci/mmol α-32 P-UTP (GE Healthcare) using T7 RNA polymerase. Molecular weight markers were prepared using RNA Century marker template set (catalog no. 7780; Ambion) transcribed using a Maxiscript kit (catalog no. 1308-1326; Ambion) with 800 Ci/mmol α-32 P-dUTP (GE Healthcare). mRNA levels were measured with an InstantImager (Packard Instrument Co.).
Statistical analysis. All data in the fi gures and text are expressed as mean ± SEM. One-way ANOVA using the Bonferroni correction was used to compare mean values between multiple groups. The Student's t test was used to compare mean values between two experimental groups. Diff erences in survival were determined using the log-rank test. p-values <0.05 were considered signifi cant. 
